Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IOBENGUANE I-123: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

61.0%
Female
39.0%
Male

Age Information

The average age of patients reporting adverse events with IOBENGUANE I-123 is 24.3 years.

Geographic Distribution

The majority of adverse event reports for IOBENGUANE I-123 originate from US.

Report Summary & Outcomes

74
Total Reports
74
As Primary/Secondary Suspect
4
Deaths Reported
6
Hospitalizations
3
Life-Threatening
1
Disabilities

Reporting Timeline

First adverse event report: 20100617. Most recent report: 20250806. View full timeline →

More About IOBENGUANE I-123

IOBENGUANE I-123 Full Profile Reports by Year Drug Interactions